NCT03831828 (ESCC) is a clinical trial in Prognosis of Patients With ESCC, sponsored by LiuJunFeng.

Who is sponsoring NCT03831828?

NCT03831828 is sponsored by LiuJunFeng.

What condition does NCT03831828 study?

NCT03831828 studies Prognosis of Patients With ESCC.

Is NCT03831828 still recruiting?

NCT03831828 is currently status unknown. Last updated 8 February 2019.

Last reviewed 2019-02-08 · How we verify

NCT03831828: ESCC

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation of Gene Status and Clinical Outcomes in ESCC

Status unknown Last updated 8 February 2019

What this trial tests

trial in Prognosis of Patients With ESCC in 46 participants. Status unknown.

Timeline

26 December 2018

Primary endpoint
1 April 2019

1 April 2019

Quick facts

Lead sponsor	LiuJunFeng
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	46
Start date	26 December 2018
Primary completion	1 April 2019
Estimated completion	1 April 2019
Sites	1 location across China

Conditions studied

Prognosis of Patients With ESCC — all drugs for Prognosis of Patients With ESCC →

Sponsor

LiuJunFeng

Who can join

Adults 30 to 80, any sex, with Prognosis of Patients With ESCC. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03831828 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by LiuJunFeng
Last refreshed: 8 February 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03831828.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing